Comparison of percutaneous 60-day peripheral nerve stimulation of the lumbar medial branches to usual care with standard interventional management for chronic low back pain—a multicenter pragmatic randomized controlled trial (RESET)
Pain Medicine · 01.04.2026 · 27 (4) · 462-473
DOI: 10.1093/pm/pnaf147 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pain Medicine, online erschienen am 25.10.2025. Verfasst von Zachary L McCormick und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, University of Utah School of Medicine, Salt Lake City, UT, United States. Hauptthemen laut MEDLINE: Low Back Pain, Chronic Pain, Transcutaneous Electric Nerve Stimulation, Pain Management. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Defense, Office of the Assistant Secretary of Defense for Health Affairs, The U.S. Army Medical Research Acquisition Activity.
Abstract (Originalsprache)
Objective
Management of refractory chronic low back pain (CLBP) includes a range of treatments (eg, physical therapy, injections, ablations, neurostimulation, surgery) with varying utilization and effectiveness. This pragmatic randomized controlled trial (RCT) evaluated the effectiveness of one treatment option, percutaneous 60-day peripheral nerve stimulation (PNS), compared to usual care with standard interventional management for CLBP.
Methods
Two hundred thirty patients with CLBP were randomized in a 1:1 ratio to Group 1 (percutaneous 60-day PNS) or Group 2 (physician-directed usual care with standard interventional management). The Primary Clinical Endpoint evaluated the proportion of participants with ≥50% reductions in CLBP at 3 months post-treatment compared to baseline.
Results
At the Primary Endpoint, a greater proportion of participants receiving percutaneous 60-day PNS (55%; n = 112; 95% confidence interval [CI] = 45-65) experienced ≥50% pain relief compared to usual care with standard interventional management (26%; n = 110; 95% CI = 17-34; P < .001). Concordant with the Primary Endpoint, percutaneous 60-day PNS also produced greater improvements in patient-centric secondary endpoints, including disability, pain interference, health-related quality of life, and analgesic consumption. Reductions in pain and resulting improvements in function were sustained through 6 months with percutaneous 60-day PNS.
Conclusions
This prospective multicenter pragmatic RCT met its Primary Clinical Endpoint and found that more participants with CLBP reported pain relief at 3 months after receiving percutaneous 60-day PNS as compared to usual care with standard interventional management. Participants treated with 60-day PNS showed greater reductions in pain and more substantial improvements in functional outcomes through 6 months. ClinicalTrials.gov NCT04246281; Primary funding: Department of Defense (DoD), with additional funding needed to complete the study provided by the study’s sponsor, SPR. The protocol is available on ClinicalTrials.gov. The statistical analysis plan and results will be made available within 12 months of the study’s completion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, University of Utah School of Medicine, Salt Lake City, UT, United States.
- Department of Physical Medicine and Rehabilitation, Central Virginia VA Health System, Richmond, VA, United States.
- Virginia iSpine Physicians, Richmond, VA, United States.
- Center for Clinical Research, Winston Salem, NC, United States.
- Premier Pain Centers, Shrewsbury, NJ, United States.
- Axis Spine Center, Coeur d'Alene, ID, United States.
ORCID-Profile: Timothy R Deer, Steven P Cohen, William H Clark, Meredith J McGee, Joseph W Boggs
Förderung
- Department of Defense
- Office of the Assistant Secretary of Defense for Health Affairs
- The U.S. Army Medical Research Acquisition Activity
- WCG Statistics Collaborative
Zitieren
APA
McCormick, Z. L., Lester, D. D., DePalma, M. J., Gilmore, C. A., Li, S., Jameson, J. B., Desai, M. J., Weaver, T. E., Lad, S. P., Davidoff, S. J., Trainor, D. M., Amirdelfan, K., Engle, M. P., Deer, T. R., Lee, T. S., Vetri, F., Bindal, M., Tornero-Bold, M. A., Nasseri, M. N., …, & Boggs, J. W. (2026). Comparison of percutaneous 60-day peripheral nerve stimulation of the lumbar medial branches to usual care with standard interventional management for chronic low back pain—a multicenter pragmatic randomized controlled trial (RESET). Pain Medicine, 27(4), 462-473. https://doi.org/10.1093/pm/pnaf147
Vancouver
McCormick ZL, Lester DD, DePalma MJ, Gilmore CA, Li S, Jameson JB, et al. Comparison of percutaneous 60-day peripheral nerve stimulation of the lumbar medial branches to usual care with standard interventional management for chronic low back pain—a multicenter pragmatic randomized controlled trial (RESET). Pain Medicine. 2026;27(4):462-473. doi:10.1093/pm/pnaf147
BibTeX
@article{McCormick2026,
author = {McCormick, Zachary L and Lester, Denise D and DePalma, Michael J and Gilmore, Christopher A and Li, Sean and Jameson, Jessica B and Desai, Mehul J and Weaver, Tristan E and Lad, Shivanand P and Davidoff, Scott J and Trainor, Drew M and Amirdelfan, Kasra and Engle, Mitchell P and Deer, Timothy R and Lee, Thomas S and Vetri, Francesco and Bindal, Meenakshi and Tornero-Bold, Melissa A and Nasseri, Morad N and Cohen, Steven P and Clark, William H and McGee, Meredith J and Boggs, Joseph W},
title = {Comparison of percutaneous 60-day peripheral nerve stimulation of the lumbar medial branches to usual care with standard interventional management for chronic low back pain—a multicenter pragmatic randomized controlled trial (RESET)},
journal = {Pain Medicine},
year = {2026},
volume = {27},
number = {4},
pages = {462--473},
doi = {10.1093/pm/pnaf147}
}
EUVIMED